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Abstract
The physiological effects of chondroitin sulfate (CS) depend on the extent of its sulfation. This study focused on the ef-
fects of highly sulfated CS with different molecular weights in normal human dermal ﬁbroblasts (NHDFs). NHDFs were 
treated with each CS. The expression of various genes was assessed by real-time PCR. Type I collagen content and elastin 
protein expression levels were assessed by ELISA and Western blotting, respectively. Disaccharide CS signiﬁcantly in-
creased the expression of genes required for extracellular matrix (collagen, type I, alpha I, decorin, elastin, lysyl oxidase, 
SMAD2 and SMAD3). In addition, we conﬁrmed that collagen and elastin increased at the protein level. In contrast, high- 
and low-molecular-weight CS polymer had no signiﬁcant effect. Therefore, highly sulfated disaccharide CS increased the ex-
pression of extracellular matrix-related genes and proteins. It may be possible that the highly sulfated disaccharide CS may 
increase ﬁrmness and elasticity of skin.
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1.　Introduction
Chondroitin sulfate (CS) is a physiologically active sub-
stance that retains moisture and is present in various parts of 
the body. It is a water-soluble polymer, a linear chain formed 
by linking disaccharides of N-acetylgalactosamine and gluc-
uronic acid. CS is present in the form of proteoglycans, which 
attach to core proteins in vivo. CS proteoglycans include 
decorin (DCN), versican and aglycan.
CS is a glycosaminoglycan, important in extracellular ma-
trix-related proteins in the body. For example, it has been re-
ported that CS increases the expression of elastin (ELN) in 
smooth muscle cells1) and that DCN (CS proteoglycan) is re-
quired for stabilizing of collagen ﬁbers2). This suggests that 
CS is an important factor in ﬁbril formation.
Collagen ﬁbers and elastic ﬁbers are the main ﬁbers in the 
skin, and type I collagen is the main component of collagen ﬁ-
ber in skin. As DCN is required to stabilize collagen ﬁbers2), 
type I collagen and DCN are important for collagen ﬁber for-
mation in the skin. ELN is the main component of elastic ﬁ-
bers. ELN is a key extracellular matrix protein that is critical 
for elasticity and resilience. SMAD2 and SMAD3 are phos-
phorylated in response to TGF-β, inducing SMAD complex 
formation. The complex translocates into the nucleus to acti-
vate the transcription of ELN genes3). Therefore, ELN, 
SMAD2 and SMAD3 are important for elastic ﬁber forma-
tion. Lysyl oxidase (LOX) plays an important role in cross-
linking elastic ﬁbers and collagen ﬁbers4).
This study investigated the effects of CS on the extracellu-
lar matrix-related genes collagen, type I, alpha I (COL1A1), 
DCN, ELN, LOX, SMAD2 and SMAD3. CS is present in the 
skin, and has a low degree of sulfation, affecting the viability 
of ﬁbroblasts5)–8). However, the effects of CS vary depending 
on the degree of sulfation. For example, CS with a high de-
gree of sulfation promotes neurite outgrowth9) and suppres-
sion of pits formed by osteoclasts, but these effects were not 
observed with CS having low sulfation10). In addition, the in-
teraction between CS and proteins varies depending on the 
extent of sulfation11)–15). Therefore, degree of sulfation is an 
important factor for effectiveness evaluation of CS, but there 
is little information on the effects of highly sulfated CS.
In contrast, hyaluronan is a member of the glycosaminogly-
cans, which includes the CS; its physiological effects differ 
depending on its molecular weight. It is therefore conceivable 
that the effects of CS are also dependent on molecular weight.
We aimed to elucidate physiological function of highly sul-
fated CS with different molecular weights. In this paper, we 
examine the effects of molecular weight of CS with 3 sulfate 
groups per unit (high degree of sulfation) by investigating the 
effects on gene expression of COL1A1, DCN, ELN, LOX, 
SMAD2 and SMAD3, and protein expression of type I colla-
gen and ELN, which are important for ﬁbril formation in nor-
mal human dermal ﬁbroblasts.
2.　Materials and Methods
2–1.　Materials
High-molecular-weight CS (average M.W.: 47,000 Da, sul-
fate group content: 38.57％) and low-molecular-weight CS 
(average M.W.: 3,700 Da, sulfate group content: 38.74％) 
(high sulfation) were obtained from Maruho Co., Ltd. (Osaka, 
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Japan). Fig. 1 shows the structure of highly sulfated CS. Di-
saccharide CS (ΔUA-2S→GalNAc-4S-6S Na2, M.W.: 707 Da) 
was purchased from Dextra Laboratories, Ltd. (Earley Gate, 
Reading, UK). 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltet-
razolium bromide (MTT) was purchased from Sigma Chemi-
cal Co. (St. Louis, MO, USA). 3,3′,5,5′-Tetramethylbenzidine 
(TMB) solution was obtained from R&D Systems, Inc. 
(McKinley Place, MN, USA). Other reagents and chemicals 
were purchased from Wako Pure Chemical Industries, Ltd. 
(Osaka, Japan).
2–2.　Cell culture
Normal human dermal ﬁbroblasts (NHDFs) were purchased 
from Kurabo Industries, Ltd. (Osaka, Japan). NHDFs were 
cultured in DMEM with 10％ FBS, under 5％ CO2, at 37℃.
2–3.　Cell viability
The effects of each CS treatment on cell viability were 
measured by MTT assay. NHDFs were seeded at 0.5×104 
cells/well in a 24 well plate (AGC Techno Glass Co., Ltd., 
Funabashi, Chiba, Japan), treated with CS and cultured for 24 
h. An MTT stock solution (5 mg/ml) was mixed with medium 
(ratio＝1 : 9). Medium containing MTT solution was added to 
each well and was incubated for 2 h with 5％ CO2 at 37℃. 
The formazan crystals that developed in each well were dis-
solved in 0.04 mol HCl/isopropyl alcohol, and were measured 
using a scanning multi-well spectrophotometer (570 nm).
2–4.　 RNA preparation and real-time polymerase chain 
reaction (RT-PCR)
NHDFs were seeded at 5.0×104 cells/well in a 60-mm dish 
(AGC Techno Glass Co., Ltd.), treated with CS in DMEM in 
10％ FBS and cultured for 12 h. Total RNA was extracted 
from cultured NHDFs treated CS using RNAiso Plus (TaKa-
Ra Bio Inc., Otsu, Shiga, Japan). The quantity and quality of 
extracted total RNA was measured by determining the 
260/280 nm ratio. RNA was synthesized to cDNA by reverse-
transcription using a Prime Script™ reagent kit (Perfect Real 
Time) (TaKaRa Bio Inc.) and a Veriti 96-well thermal cycler 
(Life Technologies Corporation, Foster City, CA, USA). Real-
time PCR was performed using SYBR Premix Ex Taq™ (Tli 
RNaseH Plus) (TaKaRa Bio Inc.) and a Step One Plus ™ Real 
Time PCR system (Life Technologies Corporation). Table 1 
shows the primers used.
2–5.　 Quantitative determination of type I collagen (com-
petitive enzyme-linked immuno sorbent assay: 
ELISA)
ELISA for quantitative determination of type I collagen 
was carried out according to the method of Rennard et al15). 
Brieﬂy, NHDFs were seeded at 8.0×104 cells/well in a 96-
well plate (AGC Techno Glass Co., Ltd.), treated with CS in 
DMEM in 1％ FBS and cultured for 72 h. NHDFs were dis-
solved to extract protein (2％ sodium dodecyl sulfate (SDS), 
10％ glycerol, 6.27 mM Tris–HCl, pH 6.8), and culture medi-
um was collected. Extracted cell protein concentration was 
determined using Lowry’s method. Proteins (human type I 
collagen; Daiichi Fine Chemical, Takaoka, Toyama, Japan) 
were coated on an ELISA plate (AGC Techno Glass Co., Ltd.) 
at 1.25 µg/ml overnight at room temperature. Type I collagen-
coated plates were washed with PBS-T (PBS in 0.05％ Tween 
20), and blocked using blocking solution (BlockAce; DS 
Pharma Biomedical, Tokyo, Japan) at 37℃ for 1 h. The cul-
ture medium were mixed with primary antibody (Biotin-anti-
type I collagen antibody; Rockland, Limerick, PA, USA), and 
were incubated at 37℃ for 1 h. Culture medium mixed with 
the primary antibody was added to the wells of the protein-
coated plate, followed by incubation at 37℃ for 1 h. Protein-
coated plates were then treated with Streptavidin-horseradish 
peroxidase (R&D Systems, Inc., Minneapolis, MN, USA), 
and incubated at 37℃ for 1 h. TMB solution was added to 
protein-coated plates, followed by incubation at room temper-
ature. Subsequently, stop solution was added, and measure-
ments were obtained with a scanning multi-well spectropho-
tometer (450 nm). A standard curve was generated using hu-
man type I collagen (Daiichi Fine Chemical) (0, 0.078, 0.158, 
0.313 and 0.625 µg/ml).
2–6.　ELN determination (Western blotting)
NHDFs were seeded at 5.0×104 cells/well in a 60-mm dish 
(AGC Techno Glass Co., Ltd.), treated with CS in DMEM in 
10％ FBS and cultured for 48 h. Proteins were extracted from 
NHDFs in the presence of disaccharide CS using a protein ex-
traction reagent (2％ SDS, 10％ glycerol, 6.27 mM Tris–HCl, 
pH 6.8). Concentration of the extracted proteins was deter-
mined using the Lowry assay. Extracted proteins were mixed 
1 : 1 with SDS-PAGE sample buffer (62.5 mM Tris–HCl, 2％ 
SDS, 10％ glycerol, 1％ bromophenol blue), and were heated 
at 95℃ for 3 min. Proteins were separated by SDS-PAGE us-
ing 7％ or 10％ acrylamide gels, and were transferred to a 
PVDF membrane at 100 V for 30 min. PVDF membrane with 
transferred protein was blocked with blocking buffer (5％ 
skim milk, 1％ Tween 20, 0.13 M NaCl, 0.02 M Tris–HCl, pH 
Fig. 1. Structure of CS. Disaccharide CS: n＝1, low molecular 
weight CS: n＝4, high molecular weight CS: n＝60–
70.
Table 1.　Primers used for real-time PCR.








*GAPDH: glyceraldehyde 3-phosphate dehydrogenase
Chondroitin Sulfate Disaccharide Enhances Extracellular Matrix-Related Gene and Protein Expression 3
7.2). PVDF membrane with transferred protein was incubated 
with primary antibodies (Rabbit Anti-elastin polyclonal anti-
body, Unconjugated; Bioss, Woburn, MA, USA; β-actin 
(13E5) Rabbit mAb; Cell Signaling Technology, Inc., Dan-
vers, MA, USA), washed with TBS-T (1％ Tween 20, 0.13 M 
NaCl, 0.02 M Tris–HCl, pH 7.2), and incubated with second-
ary antibody (ECL™ Anti-Rabbit IgG, Horseradish Peroxi-
dase linked whole antibody from Donkey; GE Healthcare, 
Little Chalfont, Buckinghamshire, UK). Protein bands were 
detected using an enhanced chemiluminescence Western blot-
ting detection kit (Amersham™ ECL™ Prime Western Blot-
ting Detection Reagent; GE Healthcare). Intensity of chemilu-
minescence was detected using a LAS-1000plus (FUJIFILM 
Corporation, Tokyo, Japan) and was analyzed by Multi Gauge 
software (FUJIFILM Corporation).
2–7.　Data analysis
Data represent means and standard deviation (n＝3–6). 
Analysis was conducted using Tukey’s multiple statistical test 
or Student’s t-test with SAS.
3.　 Results
3–1.　Cell viability and proliferation
NHDFs were treated with disaccharide CS and cell viability 
was determined after 24 h. There were no changes in viability 
at any concentration of disaccharide CS (p＞0.05) (Fig. 2). In 
addition, there were no changes in cell viability on treatment 
with 0.3 µg/ml disaccharide CS, low-molecular-weight CS or 
high-molecular-weight CS (p＞0.05) (Fig. 3).
3–2.　Gene expression levels
NHDFs were treated with CS of various molecular weights, 
and RNA was recovered after 12 h. Gene expression levels of 
COL1A1, DCN, ELN, LOX, SMAD2 and SMAD3 were then 
determined using real-time PCR. Disaccharide CS signiﬁcant-
ly increased gene expression levels of COL1A1, DCN, ELN 
and SMAD2 when compared with the normal group and the 
high-molecular-weight CS-treated group (p＜0.05). In particu-
lar, disaccharide CS signiﬁcantly increased expression levels 
of COL1A1 and DCN when compared with other groups (p＜
0.05). In addition, disaccharide CS tended to increase expres-
sion levels of LOX and SMAD3 when compared with the nor-
mal group (0.05＜p＜0.1). In contrast, low-molecular-weight 
CS signiﬁcantly increased expression levels of SMAD2 when 
compared with the normal group (p＜0.05), and tended to in-
crease expression levels of COL1A1 (0.05＜p＜0.1). Howev-
er, high-molecular-weight CS did not affect gene expression 
levels (p＞0.1) (Figs. 4a–f).
3–3.　Type I collagen and ELN expression level
Type I collagen content was quantiﬁed using ELISA. Type I 
collagen content was signiﬁcantly higher in the disaccharide 
CS-treated group (p＜0.05).
ELN protein expression levels were determined by Western 
blot. Protein expression levels of ELN were signiﬁcantly 
higher in the disaccharide CS-treated group (p＜0.05).
4.　Discussion
We focused on the effects of highly sulfated CS with differ-
ent molecular weights in normal human dermal ﬁbroblasts 
(NHDFs). First, the effects of CS treatment on cell viability 
were measured using the MTT assay. No cytotoxicity was ob-
served at any concentration of disaccharide CS, or for low-
molecular-weight or high-molecular-weight CS at 0.3 µg/ml. 
NHDFs were treated with CS of different molecular weights 
in order to evaluate the gene expression levels of extracellular 
matrix-related proteins after 12 h. Disaccharide CS signiﬁ-
cantly increased gene expression levels of COL1A1, DCN, 
ELN and SMAD2 when compared with the normal group, and 
tended to increase expression levels of LOX and SMAD3 (0.05
＜p＜0.1). However, high-molecular-weight CS did not have a 
signiﬁcant effect on gene expression levels. Type I collagen, a 
protein required for the formation of collagen ﬁbers, is abun-
dant in the skin. DCN is required to stabilize collagen ﬁbers. 
Fig. 2. Effects of various concentrations of disaccharide CS on 
cell viability in normal human dermal fibroblasts. 
NHDFs were treated for 24 h with disaccharide CS of 
different concentrations. Cell viability was determined 
by MTT assay. Values are means±S.D. (n＝4).
Fig. 3. Effects of various molecular weights of CS on cell pro-
liferation of normal human dermal ﬁbroblasts. NHDFs 
were treated for 24 h with CS (concentration: 0.3 g/ml). 
Cell proliferation was determined by MTT assay. Val-
ues are means±S.D. (n＝4). D is disaccharide CS, L is 
low molecular weight CS and H is high molecular 
weight CS.




Fig. 4. Effects of various molecular weights of CS on mRNA expression levels of extracellular matrix-related proteins in NHDF. NHDFs 
cells were incubated with 0.1 µg/ml of various molecular weight of CS (or medium) and gene expression levels were determined 
for (a) COL1A1, (b) DCN, (c) ELN, (d) LOX, (e) SMAD2 and (f) SMAD3. Gene expression was measured by real-time PCR after 
exposure to CS for 12 h. Results show relative quantiﬁcation where gene expression in control samples is “1”. mRNA levels were 
normalized by dividing by the quantity of GAPDH in each sample. Values are means±S.D. of at least three experiments (n＝3–4). 
*: p＜0.05, **: p＜ 0.01, ***: p＜ 0.001, as compared with untreated cells. Statistical analysis was conducted using Tukey’s multi-
ple statistical tests. D is disaccharide CS, L is low molecular weight CS and H is high molecular weight CS.
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ELN is the main component of elastic ﬁbers in skin. LOX 
plays an important role in cross-linking ﬁbers. SMAD2 and 
SMAD3 are necessary for the production of ELN. All six pro-
teins are important for ﬁbril formation in the skin. We investi-
gated type I collagen content and ELN protein expression lev-
els after treatment with disaccharide CS having a high degree 
of sulfation, and found that type I collagen content and ELN 
protein expression levels were signiﬁcantly higher in the di-
saccharide CS-treated group. Thus, disaccharide CS with a 
high degree of sulfation can potentially act on ﬁbroblasts to 
promote ﬁber formation.
Hyaluronan is a glycosaminoglycan whose effects vary de-
pending on its molecular weight (e.g., high molecular weight 
or low molecular weight)16)–18). High-molecular-weight hyal-
uronic acid and tetrasaccharide hyaluronan also have different 
effects on the COL1A1 gene19). Here, we showed that CS with 
a high degree of sulfation has different effects depending on 
its molecular weight (Fig. 4). Heparin is a glycosaminogly-
can. The interaction between heparin and IL-10 varies de-
pending on the molecular weight20). Therefore, it is possible 
that the afﬁnity of CS binding to protein (e.g., receptor, cyto-
kine) depends on the molecular weight of CS.
CS increased SMAD2 and SMAD3 gene expression levels. 
SMAD2 and SMAD3 are proteins in the SMAD/TGF-β path-
way. CS is known to bind to TGF-β21). Furthermore, TGF-β 
induced signaling events in human articular chondrocytes are 
inﬂuenced by exogenous chondroitin sulfate22). Therefore, 
highly sulfated disaccharide
CS might act via the SMAD/TGF-β pathway. However, the 
mechanisms for the expression of extracellular matrix-related 
proteins are unknown. Whether highly sulfated disaccharide 
CS binds directly to TGF-β or TGF receptor requires further 
investigation. However, it is also possible that CS has its own 
receptor. Whether the afﬁnity of CS-binding receptors are mo-
lecular-weight dependent requires further investigation.
Highly sulfated disaccharide CS can be delivered into the 
skin because of its low molecular weight, and as disaccharide 
CS increased the expression of extracellular matrix-related 
genes necessary for ﬁbril formation, it can be expected to im-
prove the ﬁrmness and elasticity of skin.
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